USANA HEALTH SCIENCES, INC. Restricted Cash and Cash Equivalents, Noncurrent
USANA HEALTH SCIENCES, INC. (USNA) had Restricted Cash and Cash Equivalents, Noncurrent of $2.74 million as of 2024-12-28, per its 10-K filed 2025-03-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2025-03-12
- 2024-12-28: Restricted Cash and Cash Equivalents, Noncurrent $2.74M.
- 2024-03-30: Restricted Cash and Cash Equivalents, Noncurrent $2.77M.
- 2023-12-30: Restricted Cash and Cash Equivalents, Noncurrent $2.83M.
- 2023-04-01: Restricted Cash and Cash Equivalents, Noncurrent $2.91M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2024-12-28 | $2.74M 10-K · filed 2025-03-12 |
| 2024-03-30 | $2.77M 10-Q · filed 2024-05-07 |
| 2023-12-30 | $2.83M 10-K · filed 2025-03-12 |
| 2023-04-01 | $2.91M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $2.90M 10-K · filed 2025-03-12 |
| 2022-01-01 | $3.82M 10-K · filed 2024-02-27 |
| 2020-06-27 | $2.83M 10-Q · filed 2020-08-04 |
| 2020-03-28 | $2.82M 10-Q · filed 2020-05-05 |
| 2019-12-28 | $2.86M 10-K · filed 2020-02-25 |
| 2019-09-28 | $2.81M 10-Q · filed 2019-11-05 |
| 2019-06-29 | $2.91M 10-Q · filed 2020-08-04 |
| 2019-03-30 | $2.98M 10-Q · filed 2020-05-05 |
| 2018-12-29 | $2.91M 10-K · filed 2020-02-25 |
| 2018-09-29 | $2.91M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $3.02M 10-Q · filed 2019-08-06 |
| 2018-03-31 | $3.18M 10-Q · filed 2019-05-07 |
| 2017-12-30 | $3.08M 10-K · filed 2020-02-25 |
| 2017-09-30 | $3.01M 10-Q · filed 2018-11-07 |
| 2017-07-01 | $2.95M 10-Q · filed 2018-08-08 |
| 2017-04-01 | $2.90M 10-Q · filed 2018-05-09 |
| 2016-12-31 | $2.88M 10-K · filed 2019-02-26 |
| 2016-01-02 | $3.08M 10-K · filed 2017-03-01 |
| 2015-01-03 | $3.22M 10-K · filed 2016-03-01 |
| 2013-12-28 | $3.30M 10-K · filed 2015-03-17 |
| 2012-12-29 | $3.21M 10-K · filed 2014-03-13 |
| 2011-12-31 | $3.17M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |